STATISTICAL ANALYSIS OF SAFETY DATA IN LONGTERM CLINICAL TRIALS


 Kristopher Cross
 1 years ago
 Views:
Transcription
1 STATISTICAL ANALYSIS OF SAFETY DATA IN LONGTERM CLINICAL TRIALS Tailiang Xie, Ping Zhao and Joel Waksman, Wyeth Consumer Healthcare Five Giralda Farms, Madison, NJ 794 KEY WORDS: Safety Data, Adverse Event, Statistical Analysis, Multivariate Survival Analysis, Clinical Trial. 1. Introduction In the past 4 years, approximately 15 drugs worldwide have been withdrawn from market for safetyrelated reasons since the withdrawal of thalidomide in A recent article claimed that serious adverse events (AEs) are now between the fourth and sixth leading cause of death in the United States. 2 In the ICHE9, it is clearly stated that in all clinical trials, the evaluation of safety and tolerability of a drug constitutes an important element of the overall benefit/risk assessment. 3 Over the past decades, although much research has been done and many statistical methods have been utilized for analyzing efficacy data, not much has been utilized directly for the analysis of safety data. One of the reasons might be the complicity of safety data, particularly the data from longterm trials. Unlike efficacy analysis, the Type II error is usually of more concern in the safety analysis, especially for serious AEs. Therefore, more powerful statistical methods should be used. To date, most of the analyses of safety data are routine and exploratory in nature. Listing of AEs and summary of the crude rate are among the most commonly used analyses in regulatory submissions and publications. The crude rate is defined as the number of subjects with the event occurring at any time during exposure, divided by the total number of subjects exposed, regardless of duration of exposure, and it is usually analyzed via Fisher s exact test. This crude rate method may be efficient and sufficient for acute drug use in singledose trials because the duration of drug exposure is usually short and equal among subjects 4. However, for longterm clinical trials with chronic and variable exposures and multiple incidences of AEs, the crude rate method could be invalid and misleading. There are at least three drawbacks associated with the crude rate method for longterm trials. First, because multiple incidences of an AE are counted only once for each subject during the entire trial, the crude rate method could be misleading without reference to chronic exposure of medication and multiple incidences of the same AE. Second, the crude rate method does not take into account important covariates that may have potential impacts on AE, such as demographic and baseline characteristics. Finally, the crude rate method is mostly underpowered for evaluating AE data. The purpose of this paper is to compare and discuss alternative methods for AE analysis. Methods to be discussed are the Cochran MantelHaenszel (CMH) test, Poisson regression and two multivariate survival analysis models, AndersonGill multiplicative hazards model (AG model) 5 and proportional mean model (PM model) 6. The relative performance of these procedures in terms of power and Type I error rate will be evaluated using simulation studies. 2. Aspects of Safety Data in Longterm Trials Longterm clinical trials have a number of unique aspects important to AE assessment. Compared to singledose trials, the drop out rate is usually higher in longterm trials, which results in variable duration of exposure time. Consider a longterm clinical trial illustrated in Figure 1, where there were 1, subjects enrolled in a oneyear clinical trial. Most of the subjects remained exposed during the first three months. Approximately half of the subjects dropped out after six months and only a quarter of the subjects remained active at the end of the trial. 3824
2 Figure 1. Exposure Pattern for Subjects Followedup Month of Exposure A third aspect of AE data in longterm trials is that a subject may experience multiple incidences of the same AE. Consider a 1day clinical trial, in which there were a total of 85 incidences of an AE reported by 98 subjects. A useful graphical method to show multiple AE incidences within subjects is depicted in Figure 3, where each horizontal line represents the time course of a subject who was in the trial and the dots on the line represent the onset of AE incidences for the subject. Figure 3. Example Data with Multiple Incidences of AE Number of Events A second aspect is that the time pattern of an AE might be different for different drugs. Figure 2 illustrates an example in which the AE rate was approximately the same among three treatment groups. For Drug A, most of the AE incidences occurred at the beginning of the treatment and the number of AEs gradually declined until Month 6 and eventually disappeared. This may indicate a gradual buildup of tolerance to Drug A. For Drug B, most of the AE incidences were distributed evenly during Months 16. For Drug C, there was no AE incidence until Month 3. The AE rate then peaked around Months 68. This may indicate a cumulative toxicity of Drug C. Although the crude rates were the same for all three drugs, the time course when the AE occurred was completely different. 5 Figure 2. Pattern of AEs for Three Drugs Month of Exposure Drug A Drug B Drug C Subjects Study Days Finally, a fourth aspect of longterm AE data is the dependence among AEs within a subject, in the sense that a subject who had an AE is likely to have the same AE again. For instance, multiple incidences of somnolence can be induced by certain antihistamine drugs. These aspects undoubtedly bring challenges in assessing safety and tolerability of a drug for longterm use. Clearly, the conventional crude rate method is subject to bias in analysis of longterm safety data because it throws out a great deal of information. Methods capable of capturing these aspects should be used. In the next section, the crude rate method, CMH test, Poisson regression, AG model and PM model will be compared. 3. Comparison of Statistical Methods Among the methods compared, the AG model 5 6 and PM model are relatively recent advancements of multivariate survival analysis, and will be summarized briefly. 3825
3 Let N(t) be a counting process representing number of events occurring over the time interval [, t] (t ). Assuming that N(t) is a nonhomogeneous Poisson process and letting Λ Z (t) be the cumulative intensity function of N(t), conditional on a pdimensional covariate process Z, then the AG model takes the form of β T Z ( t) Λ ( t) = e Λ ( t), Z where Λ is an unspecified continuous intensity function and β is a pvector of regression parameters. By contrast, the PM model does not impose the Poisson assumption on N(t) and takes the form of β T Z ( t ) m ( t) = e m ( t), Z where m z (t)=e{ N(t) Z }, a mean function of N(t). If N(t) is a nonhomogeneous Poisson process, then the mean function is the cumulative intensity function. Therefore, the PM model is an extension of the AG model. By assuming a nonhomogeneous Poisson structure of N(.), the AG model essentially assumes independence among events. The naïve variancecovariance estimator (i.e. the Fisher information matrix) is used. However, the PM model allows dependence among events. The robust variancecovariance estimator (i.e. the sandwich estimator) is used. The crude rate method and CMH test are nonparametric; while the Poisson regression and AG model are parametric, in that they assume the number of events follows a Poisson distribution. The PM model is a semiparametric method, in that it does not assume a specific distribution of N(t), however, it does assume a proportional structure of the mean functions between treatment groups. Among the compared methods, the PM model is the only method that is capable of capturing all of the mentioned aspects of safety data in longterm trials. A comparison of the methods is summarized in Table 1. Table 1. Comparison of Statistical Methods Aspect Consideration Method PA MT TE DP CE DE Crude No No No No No No CMH No Yes No No No No Poisson Yes Yes No No Yes No AG Yes Yes Yes No Yes Yes PM Yes* Yes Yes Yes Yes Yes *PM model is only semiparametric. PA: Parametric assumption. MT: Multiplicity. TE: Time to event. DP: Dependence. CE: Covariate effect. DE: Duration of Exposure. 4. Simulation Results A number of simulation studies were conducted to assess the performance of these methods. We focused on the following aspects of performance: power, Type I error and robustness. The number of events was first simulated via a Poisson distribution for power and Type I error assessment. To assess robustness, the number of events was then simulated via a contaminated Poisson distribution. All simulations were performed using SAS Version 6.12 (SAS Institute, Cary, NC). For Poisson regression, the SAS GENMOD procedure was used. For both the AG and PM models, the SAS PHREG procedure was used with counting process data input. For the PM model, the SAS IML procedure also was used to compute the robust covariancevariance estimator. Data with Poisson Distribution In order to assess power, the AE data sets were generated, in which the number of AEs followed Poisson distributions with rates of 1 and 1.5, and the time to AE had marginal exponential distributions with medians of 1 and 1.5 days for the reference and test treatment groups, respectively. The correlation coefficients ρ among times to AE were.,.4,.6 and.9. There were 1 subjects in each treatment group. For the Type I error assessment, the AE data sets were generated in the same manner, except that the number of AEs followed Poisson distributions with rates of 1, and the time to AE had marginal exponential distributions with medians of 1 day for both of the reference and test treatment groups. 3826
4 The simulated data were then analyzed using each of the five methods. The simulation was repeated 1, times for each combination of correlation and method, and the proportion of times the null hypothesis of equal treatment AE rates was rejected at the.5 level was recorded. Table 2 has the results. Table 2. Comparison of the Simulated Power and Type I Error ρ Method Power Type I Error. Crude CMH Poisson AG PM Crude CMH Poisson AG PM Crude CMH Poisson AG PM Crude CMH Poisson AG PM Unsurprisingly, the crude rate method had the lowest power among all methods compared. All other methods had reasonably high power, especially the AG model, which took advantage of meeting all its model assumptions and utilizing almost all the information in the data. The PM model was the second most powerful method among all methods compared. For those methods that do not take into account the dependence of AEs within subject, the power was stable. For the PM model, however, as expected the power decreased as the withinsubject correlation increased. As shown in Table 2, all methods had reasonable Type I error rate, except for the AG model that had a Type I error rate in a range of To further investigate why the AG model inflates the Type I error, we performed additional simulations as shown in Table 3. Table3.TypeIerrorforAGmodel ρ N=2 N=3 N=ranpoi() N: the number of events per subject. N=ranpoi() means the number of events following a Poisson distribution. For the cases with fixed number of events, the Type I error inflation may be due to the increasing of withinsubject correlation in the simulated data. For the case with random number of events, the inflation may be due to not only the increasing of withinsubject correlation in the simulated data, but also the violation of the proportionality property caused by the randomness of the number of events. NonPoisson Distribution Data In this simulation study, we attempted to assess the robustness of these methods under the non Poisson situation, especially for the Poisson regression and the AG model. The AE data sets were generated in a similar manner as above, in which the time to AEs was simulated with the same distribution. The number of AEs, however, was contaminated by a random noise added to the Poisson distribution in order to create overdispersion to the data. The simulation was run for 1, times for each combination of correlation and method. Because the results were consistent across different correlation coefficients, only the results for correlation of.6 are displayed. Table 4. Comparison of Power for Non Poisson Data (ρ =.6) Method Simulated Power Poisson Regression.28 AG.898 PM
5 As shown in Table 4, the powers for the Poisson regression and AG model were decreased. A severe impact was observed on the Poisson regression. For the AG model, although the Poisson condition was not held, the difference between the median times to event helped to lessen the power loss. Since the PM model is distribution free, its power remained essentially unchanged. 5. Discussion and Conclusion Since failure in detecting elevated AE rates related to a study drug could result in severe consequences, the Type II error is usually of more concern than the Type I error especially for serious AEs, in the safety analysis. The usual crude rate method is severely underpowered for longterm clinical trials. Thus it should not be used routinely for confirmatory analysis, especially for analyzing serious AEs. In addition, the crude rate method cannot factor in the effects of covariates that may affect AEs. The CMH test and Poisson regression are relatively powerful. However, neither of the methods can take into account the time course of AEs and the dependence of recurrent AEs within subjects. In addition, the Poisson regression can be severely impacted by violation of its parametric assumption. fairly easy to implement it in major software, such as SAS (PHREG and IML) and SPlus (COXPH). Thus, the PM model has the best overall performances in terms of power, Type I error rate, robustness and capacity of capturing all aspects of safety data in longterm clinical trials. References 1. SprietPourra C, Auriche M. (1994). Drug withdrawal from sale. 2 nd edition. Scrip Reports. Richmond, England: PJB Publications Ltd. 2. Lazarou J, Pomeranz BH, Corey PN. (1998). Incidence of adverse drug reactions in hospitalized patients. JAMA; 279: ICHE9. 4. O Neil RT. (1987). Statistical analysis of adverse event data from clinical trials. Special emphasis on serious events. Drug Inf. J.; 21: Anderson, P.K. and Gill, R.D. (1982). Cox s Regression Model for counting processes: a large sample study. The Annals of Statistics, 1, Lin, D.Y., Wei, L. J., Yang, I. And Ying, Z. (2). Semiparametric regression for the mean and rate functions of recurrent events. J. R. Statist. Soc. B; 62, Part 4, pp The AG model has the highest power when all conditions pertaining to its model assumption are met. However, it does not take the dependence into account. As indicated by the Table 3, it should be used with caution when the number of events was widely divergent or the time to events were clustered type data. The PM model has reasonable Type I error rate, while its power is only slightly lower than that of the AG model. It is capable of capturing all aspects of longterm safety data. In addition, it is built under a regression framework and thus able to take into account the effects of covariates such as baseline and demographic characteristics. Unlike the AG model and Poisson regression, it is robust to the violation of the underlying distribution assumption. Additionally, because it models the mean instead of intensity function as in the AG model, it is intuitive and easily interpreted. Finally, it is 3828
Survival Analysis Using SPSS. By Hui Bian Office for Faculty Excellence
Survival Analysis Using SPSS By Hui Bian Office for Faculty Excellence Survival analysis What is survival analysis Event history analysis Time series analysis When use survival analysis Research interest
More informationSAS and R calculations for cause specific hazard ratios in a competing risks analysis with time dependent covariates
SAS and R calculations for cause specific hazard ratios in a competing risks analysis with time dependent covariates Martin Wolkewitz, Ralf Peter Vonberg, Hajo Grundmann, Jan Beyersmann, Petra Gastmeier,
More informationTips for surviving the analysis of survival data. Philip TwumasiAnkrah, PhD
Tips for surviving the analysis of survival data Philip TwumasiAnkrah, PhD Big picture In medical research and many other areas of research, we often confront continuous, ordinal or dichotomous outcomes
More informationChapter 1 Introduction. 1.1 Introduction
Chapter 1 Introduction 1.1 Introduction 1 1.2 What Is a Monte Carlo Study? 2 1.2.1 Simulating the Rolling of Two Dice 2 1.3 Why Is Monte Carlo Simulation Often Necessary? 4 1.4 What Are Some Typical Situations
More informationHow to choose a statistical test. Francisco J. Candido dos Reis DGOFMRP University of São Paulo
How to choose a statistical test Francisco J. Candido dos Reis DGOFMRP University of São Paulo Choosing the right test One of the most common queries in stats support is Which analysis should I use There
More information1.0 Abstract. Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA. Keywords. Rationale and Background:
1.0 Abstract Title: Real Life Evaluation of Rheumatoid Arthritis in Canadians taking HUMIRA Keywords Rationale and Background: This abbreviated clinical study report is based on a clinical surveillance
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical
More informationIntroduction. Survival Analysis. Censoring. Plan of Talk
Survival Analysis Mark Lunt Arthritis Research UK Centre for Excellence in Epidemiology University of Manchester 01/12/2015 Survival Analysis is concerned with the length of time before an event occurs.
More informationIntroduction to Event History Analysis DUSTIN BROWN POPULATION RESEARCH CENTER
Introduction to Event History Analysis DUSTIN BROWN POPULATION RESEARCH CENTER Objectives Introduce event history analysis Describe some common survival (hazard) distributions Introduce some useful Stata
More informationDEVELOPING AN ANALYTICAL PLAN
The Fundamentals of International Clinical Research Workshop February 2004 DEVELOPING AN ANALYTICAL PLAN Mario Chen, PhD. Family Health International 1 The Analysis Plan for a Study Summary Analysis Plan:
More informationIntroduction to survival analysis
Chapter Introduction to survival analysis. Introduction In this chapter we examine another method used in the analysis of intervention trials, cohort studies and data routinely collected by hospital and
More informationSample Size and Power in Clinical Trials
Sample Size and Power in Clinical Trials Version 1.0 May 011 1. Power of a Test. Factors affecting Power 3. Required Sample Size RELATED ISSUES 1. Effect Size. Test Statistics 3. Variation 4. Significance
More informationWhen Does it Make Sense to Perform a MetaAnalysis?
CHAPTER 40 When Does it Make Sense to Perform a MetaAnalysis? Introduction Are the studies similar enough to combine? Can I combine studies with different designs? How many studies are enough to carry
More informationAge to Age Factor Selection under Changing Development Chris G. Gross, ACAS, MAAA
Age to Age Factor Selection under Changing Development Chris G. Gross, ACAS, MAAA Introduction A common question faced by many actuaries when selecting loss development factors is whether to base the selected
More informationChecklists and Examples for Registering Statistical Analyses
Checklists and Examples for Registering Statistical Analyses For welldesigned confirmatory research, all analysis decisions that could affect the confirmatory results should be planned and registered
More informationMISSING DATA TECHNIQUES WITH SAS. IDRE Statistical Consulting Group
MISSING DATA TECHNIQUES WITH SAS IDRE Statistical Consulting Group ROAD MAP FOR TODAY To discuss: 1. Commonly used techniques for handling missing data, focusing on multiple imputation 2. Issues that could
More informationSUMAN DUVVURU STAT 567 PROJECT REPORT
SUMAN DUVVURU STAT 567 PROJECT REPORT SURVIVAL ANALYSIS OF HEROIN ADDICTS Background and introduction: Current illicit drug use among teens is continuing to increase in many countries around the world.
More informationUNDERSTANDING CLINICAL TRIAL STATISTICS. Prepared by Urania Dafni, Xanthi Pedeli, Zoi Tsourti
UNDERSTANDING CLINICAL TRIAL STATISTICS Prepared by Urania Dafni, Xanthi Pedeli, Zoi Tsourti DISCLOSURES Urania Dafni has reported no conflict of interest Xanthi Pedeli has reported no conflict of interest
More informationFairfield Public Schools
Mathematics Fairfield Public Schools AP Statistics AP Statistics BOE Approved 04/08/2014 1 AP STATISTICS Critical Areas of Focus AP Statistics is a rigorous course that offers advanced students an opportunity
More informationIntroduction to Fixed Effects Methods
Introduction to Fixed Effects Methods 1 1.1 The Promise of Fixed Effects for Nonexperimental Research... 1 1.2 The PairedComparisons ttest as a Fixed Effects Method... 2 1.3 Costs and Benefits of Fixed
More informationHow to interpret scientific & statistical graphs
How to interpret scientific & statistical graphs Theresa A Scott, MS Department of Biostatistics theresa.scott@vanderbilt.edu http://biostat.mc.vanderbilt.edu/theresascott 1 A brief introduction Graphics:
More informationAntipsychotic drugs are the cornerstone of treatment
Article Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic T. Scott Stroup, M.D.,
More informationPROPERTIES OF THE SAMPLE CORRELATION OF THE BIVARIATE LOGNORMAL DISTRIBUTION
PROPERTIES OF THE SAMPLE CORRELATION OF THE BIVARIATE LOGNORMAL DISTRIBUTION ChinDiew Lai, Department of Statistics, Massey University, New Zealand John C W Rayner, School of Mathematics and Applied Statistics,
More informationStatistics and research
Statistics and research Usaneya Perngparn Chitlada Areesantichai Drug Dependence Research Center (WHOCC for Research and Training in Drug Dependence) College of Public Health Sciences Chulolongkorn University,
More informationCancer Survival Analysis
Cancer Survival Analysis 2 Analysis of cancer survival data and related outcomes is necessary to assess cancer treatment programs and to monitor the progress of regional and national cancer control programs.
More informationStatistics Graduate Courses
Statistics Graduate Courses STAT 7002Topics in StatisticsBiological/Physical/Mathematics (cr.arr.).organized study of selected topics. Subjects and earnable credit may vary from semester to semester.
More informationIntroduction. Ethical Issues in the Statistical Analysis of Clinical Research Data. Introduction. Introduction. Statistical Quality or Ethical Degree
Ethical Issues in the Statistical Analysis of Clinical Research Data Roger J. Lewis, MD, PhD Department of Emergency Medicine HarborUCLA Medical Center Torrance, California Introduction Types of datacentered
More informationTUTORIAL on ICH E9 and Other Statistical Regulatory Guidance. Session 1: ICH E9 and E10. PSI Conference, May 2011
TUTORIAL on ICH E9 and Other Statistical Regulatory Guidance Session 1: PSI Conference, May 2011 Kerry Gordon, Quintiles 1 E9, and how to locate it 2 ICH E9 Statistical Principles for Clinical Trials (Issued
More informationChecking proportionality for Cox s regression model
Checking proportionality for Cox s regression model by Hui Hong Zhang Thesis for the degree of Master of Science (Master i Modellering og dataanalyse) Department of Mathematics Faculty of Mathematics and
More informationBasic research methods. Basic research methods. Question: BRM.2. Question: BRM.1
BRM.1 The proportion of individuals with a particular disease who die from that condition is called... BRM.2 This study design examines factors that may contribute to a condition by comparing subjects
More informationMISSING DATA: THE POINT OF VIEW OF ETHICAL COMMITTEES
I CONGRESSO NAZIONALE BIAS 2009 29/30 APRILE 2009 ELI LILLY SESTO FIORENTINO (FI) MISSING DATA: THE POINT OF VIEW OF ETHICAL COMMITTEES Anna Chiara Frigo Department of Environmental Medicine and Public
More informationModule 9: Nonparametric Tests. The Applied Research Center
Module 9: Nonparametric Tests The Applied Research Center Module 9 Overview } Nonparametric Tests } Parametric vs. Nonparametric Tests } Restrictions of Nonparametric Tests } OneSample ChiSquare Test
More informationMinitab Guide. This packet contains: A Friendly Guide to Minitab. Minitab StepByStep
Minitab Guide This packet contains: A Friendly Guide to Minitab An introduction to Minitab; including basic Minitab functions, how to create sets of data, and how to create and edit graphs of different
More informationINTERPRETING THE REPEATEDMEASURES ANOVA
INTERPRETING THE REPEATEDMEASURES ANOVA USING THE SPSS GENERAL LINEAR MODEL PROGRAM RM ANOVA In this scenario (based on a RM ANOVA example from Leech, Barrett, and Morgan, 2005) each of 12 participants
More informationTests for Two Survival Curves Using Cox s Proportional Hazards Model
Chapter 730 Tests for Two Survival Curves Using Cox s Proportional Hazards Model Introduction A clinical trial is often employed to test the equality of survival distributions of two treatment groups.
More informationApplied Statistics. J. Blanchet and J. Wadsworth. Institute of Mathematics, Analysis, and Applications EPF Lausanne
Applied Statistics J. Blanchet and J. Wadsworth Institute of Mathematics, Analysis, and Applications EPF Lausanne An MSc Course for Applied Mathematicians, Fall 2012 Outline 1 Model Comparison 2 Model
More informationStudy Design and Statistical Analysis
Study Design and Statistical Analysis Anny H Xiang, PhD Department of Preventive Medicine University of Southern California Outline Designing Clinical Research Studies Statistical Data Analysis Designing
More informationNon Parametric Inference
Maura Department of Economics and Finance Università Tor Vergata Outline 1 2 3 Inverse distribution function Theorem: Let U be a uniform random variable on (0, 1). Let X be a continuous random variable
More informationA Mixed Model Approach for IntenttoTreat Analysis in Longitudinal Clinical Trials with Missing Values
Methods Report A Mixed Model Approach for IntenttoTreat Analysis in Longitudinal Clinical Trials with Missing Values Hrishikesh Chakraborty and Hong Gu March 9 RTI Press About the Author Hrishikesh Chakraborty,
More informationPrimary Prevention of Cardiovascular Disease with a Mediterranean diet
Primary Prevention of Cardiovascular Disease with a Mediterranean diet Alejandro Vicente Carrillo, Brynja Ingadottir, Anne Fältström, Evelyn Lundin, Micaela Tjäderborn GROUP 2 Background The traditional
More informationSUGI 29 Statistics and Data Analysis
Paper 19529 "Proc Power in SAS 9.1" Debbie Bauer, MS, SanofiSynthelabo, Russell Lavery, Contractor, About Consulting, Chadds Ford, PA ABSTRACT Features were added to SAS V9.1 STAT that will allow many
More informationCOMPARING DATA ANALYSIS TECHNIQUES FOR EVALUATION DESIGNS WITH NON NORMAL POFULP_TIOKS Elaine S. Jeffers, University of Maryland, Eastern Shore*
COMPARING DATA ANALYSIS TECHNIQUES FOR EVALUATION DESIGNS WITH NON NORMAL POFULP_TIOKS Elaine S. Jeffers, University of Maryland, Eastern Shore* The data collection phases for evaluation designs may involve
More informationStudy Design. Date: March 11, 2003 Reviewer: Jawahar Tiwari, Ph.D. Ellis Unger, M.D. Ghanshyam Gupta, Ph.D. Chief, Therapeutics Evaluation Branch
BLA: STN 103471 Betaseron (Interferon β1b) for the treatment of secondary progressive multiple sclerosis. Submission dated June 29, 1998. Chiron Corp. Date: March 11, 2003 Reviewer: Jawahar Tiwari, Ph.D.
More informationDesign and Analysis of Phase III Clinical Trials
Cancer Biostatistics Center, Biostatistics Shared Resource, Vanderbilt University School of Medicine June 19, 2008 Outline 1 Phases of Clinical Trials 2 3 4 5 6 Phase I Trials: Safety, Dosage Range, and
More informationService courses for graduate students in degree programs other than the MS or PhD programs in Biostatistics.
Course Catalog In order to be assured that all prerequisites are met, students must acquire a permission number from the education coordinator prior to enrolling in any Biostatistics course. Courses are
More informationResearch Methods & Experimental Design
Research Methods & Experimental Design 16.422 Human Supervisory Control April 2004 Research Methods Qualitative vs. quantitative Understanding the relationship between objectives (research question) and
More informationBrief Communications. Awad Mohamed Ahmed, MD. Abstract
Awad Mohamed Ahmed, MD Professor of Medicine, University of Bahr Elghazal, Khartoum, Sudan For correspondence Professor Awad Mohamed Ahmed Email: awad.sd@gmail.com Tel.: +249 912344936 Abstract Randomized
More informationAssociation Between Variables
Contents 11 Association Between Variables 767 11.1 Introduction............................ 767 11.1.1 Measure of Association................. 768 11.1.2 Chapter Summary.................... 769 11.2 Chi
More informationDescriptive Statistics
Descriptive Statistics Primer Descriptive statistics Central tendency Variation Relative position Relationships Calculating descriptive statistics Descriptive Statistics Purpose to describe or summarize
More informationCome scegliere un test statistico
Come scegliere un test statistico Estratto dal Capitolo 37 of Intuitive Biostatistics (ISBN 0195086074) by Harvey Motulsky. Copyright 1995 by Oxfd University Press Inc. (disponibile in Iinternet) Table
More informationTests of relationships between variables Chisquare Test Binomial Test Run Test for Randomness OneSample KolmogorovSmirnov Test.
N. Uttam Singh, Aniruddha Roy & A. K. Tripathi ICAR Research Complex for NEH Region, Umiam, Meghalaya uttamba@gmail.com, aniruddhaubkv@gmail.com, aktripathi2020@yahoo.co.in Non Parametric Tests: Hands
More information200609  ATV  Lifetime Data Analysis
Coordinating unit: Teaching unit: Academic year: Degree: ECTS credits: 2015 200  FME  School of Mathematics and Statistics 715  EIO  Department of Statistics and Operations Research 1004  UB  (ENG)Universitat
More informationWhen to Use Which Statistical Test
When to Use Which Statistical Test Rachel Lovell, Ph.D., Senior Research Associate Begun Center for Violence Prevention Research and Education Jack, Joseph, and Morton Mandel School of Applied Social Sciences
More informationSample Size Planning, Calculation, and Justification
Sample Size Planning, Calculation, and Justification Theresa A Scott, MS Vanderbilt University Department of Biostatistics theresa.scott@vanderbilt.edu http://biostat.mc.vanderbilt.edu/theresascott Theresa
More informationSTATISTICAL MODELING OF LONGITUDINAL SURVEY DATA WITH BINARY OUTCOMES
STATISTICAL MODELING OF LONGITUDINAL SURVEY DATA WITH BINARY OUTCOMES A Thesis Submitted to the College of Graduate Studies and Research in Partial Fulfillment of the Requirements for the Degree of Doctor
More informationGuideline on missing data in confirmatory clinical trials
2 July 2010 EMA/CPMP/EWP/1776/99 Rev. 1 Committee for Medicinal Products for Human Use (CHMP) Guideline on missing data in confirmatory clinical trials Discussion in the Efficacy Working Party June 1999/
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. Current Step 4 version
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE THE EXTENT OF POPULATION EXPOSURE TO ASSESS CLINICAL
More information7.1 The Hazard and Survival Functions
Chapter 7 Survival Models Our final chapter concerns models for the analysis of data which have three main characteristics: (1) the dependent variable or response is the waiting time until the occurrence
More informationCan I have FAITH in this Review?
Can I have FAITH in this Review? Find Appraise Include Total Heterogeneity Paul Glasziou Centre for Research in Evidence Based Practice Bond University What do you do? For an acutely ill patient, you do
More informationNonparametric Statistics
Nonparametric Statistics J. Lozano University of Goettingen Department of Genetic Epidemiology Interdisciplinary PhD Program in Applied Statistics & Empirical Methods Graduate Seminar in Applied Statistics
More informationTtest & factor analysis
Parametric tests Ttest & factor analysis Better than non parametric tests Stringent assumptions More strings attached Assumes population distribution of sample is normal Major problem Alternatives Continue
More informationECON 142 SKETCH OF SOLUTIONS FOR APPLIED EXERCISE #2
University of California, Berkeley Prof. Ken Chay Department of Economics Fall Semester, 005 ECON 14 SKETCH OF SOLUTIONS FOR APPLIED EXERCISE # Question 1: a. Below are the scatter plots of hourly wages
More informationSample Size Estimation and Power Analysis
yumi Shintani, Ph.D., M.P.H. Sample Size Estimation and Power nalysis March 2008 yumi Shintani, PhD, MPH Department of Biostatistics Vanderbilt University 1 researcher conducted a study comparing the effect
More informationClinical Study Synopsis for Public Disclosure
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis  which is part of the clinical
More informationApplications of Structural Equation Modeling in Social Sciences Research
American International Journal of Contemporary Research Vol. 4 No. 1; January 2014 Applications of Structural Equation Modeling in Social Sciences Research Jackson de Carvalho, PhD Assistant Professor
More informationProbability Calculator
Chapter 95 Introduction Most statisticians have a set of probability tables that they refer to in doing their statistical wor. This procedure provides you with a set of electronic statistical tables that
More informationMeasures of Underlying Inflation
Measures of Underlying Inflation Tony Richards and Tom Rosewall* Various measures of underlying inflation are used at the Reserve Bank. These measures are useful in assessing current inflation pressures
More informationMeasuring reliability and agreement
Measuring reliability and agreement Madhukar Pai, MD, PhD Assistant Professor of Epidemiology, McGill University Montreal, Canada Professor Extraordinary, Stellenbosch University, S Africa Email: madhukar.pai@mcgill.ca
More informationModelling spousal mortality dependence: evidence of heterogeneities and implications
1/23 Modelling spousal mortality dependence: evidence of heterogeneities and implications Yang Lu Scor and AixMarseille School of Economics Lyon, September 2015 2/23 INTRODUCTION 3/23 Motivation It has
More informationHypothesis testing S2
Basic medical statistics for clinical and experimental research Hypothesis testing S2 Katarzyna Jóźwiak k.jozwiak@nki.nl 2nd November 2015 1/43 Introduction Point estimation: use a sample statistic to
More informationBusiness Statistics. Successful completion of Introductory and/or Intermediate Algebra courses is recommended before taking Business Statistics.
Business Course Text Bowerman, Bruce L., Richard T. O'Connell, J. B. Orris, and Dawn C. Porter. Essentials of Business, 2nd edition, McGrawHill/Irwin, 2008, ISBN: 9780073319889. Required Computing
More informationWHAT IS A JOURNAL CLUB?
WHAT IS A JOURNAL CLUB? With its September 2002 issue, the American Journal of Critical Care debuts a new feature, the AJCC Journal Club. Each issue of the journal will now feature an AJCC Journal Club
More informationModeling Customer Lifetime Value Using Survival Analysis An Application in the Telecommunications Industry
Paper 12028 Modeling Customer Lifetime Value Using Survival Analysis An Application in the Telecommunications Industry Junxiang Lu, Ph.D. Overland Park, Kansas ABSTRACT Increasingly, companies are viewing
More informationMethods for Metaanalysis in Medical Research
Methods for Metaanalysis in Medical Research Alex J. Sutton University of Leicester, UK Keith R. Abrams University of Leicester, UK David R. Jones University of Leicester, UK Trevor A. Sheldon University
More informationExtending Hypothesis Testing. pvalues & confidence intervals
Extending Hypothesis Testing pvalues & confidence intervals So far: how to state a question in the form of two hypotheses (null and alternative), how to assess the data, how to answer the question by
More informationChisquare test Fisher s Exact test
Lesson 1 Chisquare test Fisher s Exact test McNemar s Test Lesson 1 Overview Lesson 11 covered two inference methods for categorical data from groups Confidence Intervals for the difference of two proportions
More informationComparison/Control Groups. Mary Foulkes, PhD Johns Hopkins University
This work is licensed under a Creative Commons AttributionNonCommercialShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationGuidance for Industry
Guidance for Industry Clinical Studies Section of Labeling for Human Prescription Drug and Biological Products Content and Format U.S. Department of Health and Human Services Food and Drug Administration
More informationBIOSTATISTICS QUIZ ANSWERS
BIOSTATISTICS QUIZ ANSWERS 1. When you read scientific literature, do you know whether the statistical tests that were used were appropriate and why they were used? a. Always b. Mostly c. Rarely d. Never
More informationPlacement Stability and Number of Children in a Foster Home. Mark F. Testa. Martin Nieto. Tamara L. Fuller
Placement Stability and Number of Children in a Foster Home Mark F. Testa Martin Nieto Tamara L. Fuller Children and Family Research Center School of Social Work University of Illinois at UrbanaChampaign
More informationMultivariate Analysis of Variance (MANOVA): I. Theory
Gregory Carey, 1998 MANOVA: I  1 Multivariate Analysis of Variance (MANOVA): I. Theory Introduction The purpose of a t test is to assess the likelihood that the means for two groups are sampled from the
More informationSAMPLE SIZE TABLES FOR LOGISTIC REGRESSION
STATISTICS IN MEDICINE, VOL. 8, 795802 (1989) SAMPLE SIZE TABLES FOR LOGISTIC REGRESSION F. Y. HSIEH* Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, N Y 10461,
More informationSpatial Statistics Chapter 3 Basics of areal data and areal data modeling
Spatial Statistics Chapter 3 Basics of areal data and areal data modeling Recall areal data also known as lattice data are data Y (s), s D where D is a discrete index set. This usually corresponds to data
More informationSemester 2 Statistics Short courses
Semester 2 Statistics Short courses Course: STAA0001  Basic Statistics Blackboard Site: STAA0001 Dates: Sat 10 th Sept and 22 Oct 2016 (9 am 5 pm) Room EN409 Assumed Knowledge: None Day 1: Exploratory
More informationThis clinical study synopsis is provided in line with Boehringer Ingelheim s Policy on Transparency and Publication of Clinical Study Data.
abcd Clinical Study for Public Disclosure This clinical study synopsis is provided in line with s Policy on Transparency and Publication of Clinical Study Data. The synopsis which is part of the clinical
More informationSENSITIVITY ANALYSIS AND INFERENCE. Lecture 12
This work is licensed under a Creative Commons AttributionNonCommercialShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationSTATISTICA Formula Guide: Logistic Regression. Table of Contents
: Table of Contents... 1 Overview of Model... 1 Dispersion... 2 Parameterization... 3 SigmaRestricted Model... 3 Overparameterized Model... 4 Reference Coding... 4 Model Summary (Summary Tab)... 5 Summary
More informationAdditional sources Compilation of sources: http://lrs.ed.uiuc.edu/tseportal/datacollectionmethodologies/jintselink/tselink.htm
Mgt 540 Research Methods Data Analysis 1 Additional sources Compilation of sources: http://lrs.ed.uiuc.edu/tseportal/datacollectionmethodologies/jintselink/tselink.htm http://web.utk.edu/~dap/random/order/start.htm
More informationSome Critical Information about SOME Statistical Tests and Measures of Correlation/Association
Some Critical Information about SOME Statistical Tests and Measures of Correlation/Association This information is adapted from and draws heavily on: Sheskin, David J. 2000. Handbook of Parametric and
More informationHumulin (LY041001) Page 1 of 1
(LY041001) These clinical study results are supplied for informational purposes only in the interests of scientific disclosure. They are not intended to substitute for the FDAapproved package insert or
More informationOverview. Longitudinal Data Variation and Correlation Different Approaches. Linear Mixed Models Generalized Linear Mixed Models
Overview 1 Introduction Longitudinal Data Variation and Correlation Different Approaches 2 Mixed Models Linear Mixed Models Generalized Linear Mixed Models 3 Marginal Models Linear Models Generalized Linear
More informationTwoSample TTests Allowing Unequal Variance (Enter Difference)
Chapter 45 TwoSample TTests Allowing Unequal Variance (Enter Difference) Introduction This procedure provides sample size and power calculations for one or twosided twosample ttests when no assumption
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POINTS TO CONSIDER ON MULTIPLICITY ISSUES IN CLINICAL TRIALS
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 19 September 2002 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) POINTS TO CONSIDER ON MULTIPLICITY
More informationMultiple logistic regression analysis of cigarette use among high school students
Multiple logistic regression analysis of cigarette use among high school students ABSTRACT Joseph AdwereBoamah Alliant International University A binary logistic regression analysis was performed to predict
More informationStudy Guide for the Final Exam
Study Guide for the Final Exam When studying, remember that the computational portion of the exam will only involve new material (covered after the second midterm), that material from Exam 1 will make
More informationTime series analysis as a framework for the characterization of waterborne disease outbreaks
Interdisciplinary Perspectives on Drinking Water Risk Assessment and Management (Proceedings of the Santiago (Chile) Symposium, September 1998). IAHS Publ. no. 260, 2000. 127 Time series analysis as a
More information200627  AC  Clinical Trials
Coordinating unit: Teaching unit: Academic year: Degree: ECTS credits: 2014 200  FME  School of Mathematics and Statistics 715  EIO  Department of Statistics and Operations Research MASTER'S DEGREE
More informationInterpreting Market Responses to Economic Data
Interpreting Market Responses to Economic Data Patrick D Arcy and Emily Poole* This article discusses how bond, equity and foreign exchange markets have responded to the surprise component of Australian
More informationSupplementary webappendix
Supplementary webappendix This webappendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Giovannoni G, Gold R, Selmaj K, et al,
More informationPermutation Tests for Comparing Two Populations
Permutation Tests for Comparing Two Populations Ferry Butar Butar, Ph.D. JaeWan Park Abstract Permutation tests for comparing two populations could be widely used in practice because of flexibility of
More information